MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma

Pancreas

Volumn 41, Issue 5, 2012, Pages 685-690

  Panarelli, Nicole C ^a   Chen, Yao Tseng ^a   Zhou, Xi K ^a   Kitabayashi, Naoki ^a   Yantiss, Rhonda K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytology; Fine needle aspiration; Intraductal papillary mucinous neoplasm; Molecular; Pancreas

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 155; MICRORNA 181B; MICRORNA 196A; MICRORNA 21; MICRORNA 217; MICRORNA 221; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CYTOPATHOLOGY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MICROARRAY ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, PANCREATIC DUCTAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863727479     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318243a905     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Sood P, Krek A, Zavolan M, et al. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A. 2006;103:2746-2751.
3. Tam W. The emergent role of microRNAs in molecular diagnostics of cancer. J Mol Diagn. 2008;10(5):415-423.
4. Zhang W, Dahlberg JE, Tam W. MicroRNAs in tumorigenesis: a primer. Am J Pathol. 2007;171:728-738.
5. Szafranska AE, Davidson T, Shingara J, et al. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn. 2008;10:415-423.
6. Jeffrey SS. Cancer biomarker profiling with microRNAs. Nat Biotechnol. 2008;26:400-401.
7. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
8. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462-469.
9. Bloom G, Yang IV, Boulware D, et al. Multi-platform, multi-site, microarray-based tumor classification. Am J Pathol. 2004;164:9-16.
10. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901-1908.
11. Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120:1046-1054.
12. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26:4442-4452.
13. Zhu Z, Gao W, Qian Z, et al. Genetic variation of miRNA sequence in pancreatic cancer. Acta Biochim Biophys Sin. 2009;41(5):407-413.
14. Longnecker DS, Adler G, Hruban RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000.
15. Wittenkind C, Greene FL, Hutter R V P, Klimpfinger M, Sobin LH, eds. TNM Atlas: Illustrated Guide to the TNM Classification of Malignant Tumors. 5th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2005.
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. New York, NY: Springer; 2010.
17. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNA in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem. 2008;54(10):1716-1724.
18. Itoi T, Takei K, Sofuni A, et al. Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses. Oncol Rep. 2005;13:229-234.
19. Chhieng DC, Benson E, Eltoum I, et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer. 2003;99:365-371.
20. Jhala N, Jhala D, Vickers SM, et al. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol. 2006;126:572-579.
21. Yantiss RK, Cosar E, Fischer AH. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. Acta Cytol. 2008;52(2):133-138.
22. Zhao H, Mandich D, Cartun RW, et al. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol. 2007;35(11):700-704.
23. Ligato S, Zhao H, Mandich D, et al. KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreatobiliary malignancies. Diagn Cytopathol. 2008;36(8):561-567.
24. Yan L, McFaul C, Howes N. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology. 2005;128:2124-2130.
25. Shi C, Fukushima N, Abe T, et al. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection. Cancer Biol Ther. 2008;7(3):353-360.
26. Hollstein M, Sidransky D, Vogelstein B. p53 mutations in human cancers. Science. 1991;253:49-53.
27. Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol. 2007;34(4):303-310.
28. Fukushima N, Walter KM, Ueki T. Diagnosing pancreatic cancer using methylation specific PCR analysis pancreatic juice. Cancer Biol Ther. 2003;2:78-83.
29. Matsubayashi H, Canto M, Sato N, et al. DNA methylation alterations in pancreatic juice of patients with suspected pancreatic disease. Cancer Res. 2006;66(2):1208-1217.
30. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029-6033.
31. Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006;24(29):4677-4684.
32. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257-2261.
33. Mardin WA, Mees ST. MicroRNAs: novel diagnostic and therapeutic tool for pancreatic ductal adenocarcinoma? Ann Surg Oncol. 2009;16(11):3183-3189.
34. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065-7070.
35. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene. 2008;27:6667-6678.
36. Maru DM, Singh RR, Hannah C, et al. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009;174(5):1940-1948.
37. Pallante P, Visone R, Ferracin M, et al. MicroRNA deregulation in human thyroid papillary carcinoma. Endocr Relat Cancer. 2006;13(2):497-508.
38. Zanette DL, Rivadavia F, Molfetta GA, et al. MiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res. 2007;40(11):1435-1440.
39. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299(4):425-436.
40. Yan LX, Huang XF, Shao Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14(11):2348-2360.
41. Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334(4):1351-1358.
42. He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005;102(52):19075-19080.
43. le Sage C, Nagel R, Egan DA, et al. Regulation of the p27 (Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007;26(15):3699-3708.
44. du Rieu MC, Torrisani J, Selves J, et al. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem. 2010;56(4):1-10.
45. Dillhoff M, Liu J, Frankel W, et al. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008;12:2171-2176.
46. Stuckenholz C, Lu L, Thakur P, et al. FACS-assisted microarray profiling implicates novel genes and pathways in zebrafish gastrointestinal tract development. Gastroenterology. 2009;137:1321-1332.